Jim has dedicated his biopharmaceutical career to creating innovative delivery devices that help people take their medicine as conveniently as possible. His passion lies in helping people by developing individuals, teams, and products that can make the world a better place.

He built two of the best delivery device development teams in the BioPharmaceutical industry at Eli Lilly and Sanofi. Using human-centered design principles, he partnered with world-class design, development, and manufacturing companies to ideate, develop, and launch multiple market-leading delivery device technologies.

Strategic organizational execution has been a key focus for Jim, including building and organizing industry-leading R&D teams, creating external executive partnerships, managing strategic alliances, technology evaluation, contract negotiation, and board representation.

Key accomplishments include the creation at Lilly of market-leading insulin KwikPen Platform, the Trulicity pen Platform, the Talz pen Platform, the Savvio Pen, the Forteo Pen, and many others. At Sanofi, multiple devices were developed for Toujeo, Soliqua, Praluent, Kevzara, and Dupixent, including the development and launch of a number of first-to-market delivery systems such as the first 2mL PFS safety system with BD, and the first-to-market 2mL autoinjector in partnership with SHL.

Jim thoroughly enjoys working with people at all levels and at different companies. He strives to share his experience, including any mistakes, insights, challenges, and opportunities, to help develop the person or the product in a way that can hopefully change the world for the better.

Back to company leadership